Literature DB >> 15136724

Albumin mediates the transcytosis of myeloperoxidase by means of caveolae in endothelial cells.

Chinnaswamy Tiruppathi1, Tabassum Naqvi, Yubin Wu, Stephen M Vogel, Richard D Minshall, Asrar B Malik.   

Abstract

Myeloperoxidase (MPO), the phagocyte hemoprotein involved in neutrophil host defense and consuming nitric oxide (*NO), induces the nitration of extracellular matrix proteins and tissue remodeling subsequent to its transcytosis across the endothelial barrier. We addressed the role of an interaction of MPO with albumin as a requirement for MPO transport across the endothelium. Matrix-assisted laser desorption/ionization MS analysis of 80- and 60-kDa proteins purified from human lung tissue [with a human serum albumin (HSA)-affinity column] identified these albumin-binding proteins as MPO and MPO-heavy chain. A peptide corresponding to the MPO-heavy chain residues 425-454 demonstrated high-affinity binding to HSA. Replacement of the positively charged residues, R and K with G, prevented the binding of HSA to the peptide. We observed that albumin increased the binding of (125)I-MPO to lung microvascular endothelial cells by 2-fold and the rate of transendothelial flux of (125)I-MPO in cultured monolayers and intact vessels. Disruption of caveolae with cyclodextrin prevented the albumin-induced increase in transendothelial flux of (125)I-MPO. We also observed by confocal imaging that albumin induced the rapid internalization of MPO and its colocalization with albumin-labeled vesicles. MPO colocalized with the caveolae markers cholera toxin subunit B and caveolin 1 in the endocytosed vesicles. Thus, transcytosis of MPO by caveolae induced by its charge-dependent interaction with albumin is an important means of delivering MPO to the subendothelial space. Albumin-mediated transport of MPO may thereby regulate NO bioavailability and formation of NO-derived oxidants in the vessel wall.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15136724      PMCID: PMC419669          DOI: 10.1073/pnas.0401712101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Quantitative analysis of albumin uptake and transport in the rat microvessel endothelial monolayer.

Authors:  Theresa A John; Stephen M Vogel; Chinnaswamy Tiruppathi; Asrar B Malik; Richard D Minshall
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2003-01       Impact factor: 5.464

Review 2.  Neutrophil-mediated vascular injury.

Authors:  J M Harlan
Journal:  Acta Med Scand Suppl       Date:  1987

3.  Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons.

Authors:  M Karas; F Hillenkamp
Journal:  Anal Chem       Date:  1988-10-15       Impact factor: 6.986

4.  M12 protein from Streptococcus pyogenes is a receptor for immunoglobulin G3 and human albumin.

Authors:  D S Retnoningrum; P P Cleary
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

Review 5.  Neutrophils and the adult respiratory distress syndrome.

Authors:  R M Tate; J E Repine
Journal:  Am Rev Respir Dis       Date:  1983-09

6.  Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions.

Authors:  A Daugherty; J L Dunn; D L Rateri; J W Heinecke
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

7.  Prognostic value of myeloperoxidase in patients with chest pain.

Authors:  Marie-Luise Brennan; Marc S Penn; Frederick Van Lente; Vijay Nambi; Mehdi H Shishehbor; Ronnier J Aviles; Marlene Goormastic; Michael L Pepoy; Ellen S McErlean; Eric J Topol; Steven E Nissen; Stanley L Hazen
Journal:  N Engl J Med       Date:  2003-10-23       Impact factor: 91.245

Review 8.  Caveolae: mining little caves for new cancer targets.

Authors:  Lucy A Carver; Jan E Schnitzer
Journal:  Nat Rev Cancer       Date:  2003-08       Impact factor: 60.716

9.  Spatial mapping of pulmonary and vascular nitrotyrosine reveals the pivotal role of myeloperoxidase as a catalyst for tyrosine nitration in inflammatory diseases.

Authors:  Stephan Baldus; Jason P Eiserich; Marie-Luise Brennan; Robert M Jackson; C Bruce Alexander; Bruce A Freeman
Journal:  Free Radic Biol Med       Date:  2002-10-01       Impact factor: 7.376

10.  Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes.

Authors:  Stephan Baldus; Christopher Heeschen; Thomas Meinertz; Andreas M Zeiher; Jason P Eiserich; Thomas Münzel; Maarten L Simoons; Christian W Hamm
Journal:  Circulation       Date:  2003-09-02       Impact factor: 29.690

View more
  36 in total

Review 1.  Integration of the extranuclear and nuclear actions of estrogen.

Authors:  Ellis R Levin
Journal:  Mol Endocrinol       Date:  2005-02-10

2.  Selective binding of biotinylated albumin to the lymphoid microvasculature.

Authors:  Péter Balogh; Andrea Petz
Journal:  Histochem Cell Biol       Date:  2005-04-26       Impact factor: 4.304

3.  Myeloperoxidase interacts with endothelial cell-surface cytokeratin 1 and modulates bradykinin production by the plasma Kallikrein-Kinin system.

Authors:  Joshua M Astern; William F Pendergraft; Ronald J Falk; J Charles Jennette; Alvin H Schmaier; Fakhri Mahdi; Gloria A Preston
Journal:  Am J Pathol       Date:  2007-07       Impact factor: 4.307

Review 4.  The inner blood-retinal barrier: Cellular basis and development.

Authors:  Mónica Díaz-Coránguez; Carla Ramos; David A Antonetti
Journal:  Vision Res       Date:  2017-06-27       Impact factor: 1.886

Review 5.  Myeloperoxidase: A new player in autoimmunity.

Authors:  Anna Strzepa; Kirkwood A Pritchard; Bonnie N Dittel
Journal:  Cell Immunol       Date:  2017-05-10       Impact factor: 4.868

6.  Effects of S-allyl cysteine on lung and liver tissue in a rat model of lipopolysaccharide-induced sepsis.

Authors:  Orhan Bayraktar; Neslihan Tekin; Ozlem Aydın; Fahrettin Akyuz; Ahmet Musmul; Dilek Burukoglu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-12-06       Impact factor: 3.000

7.  Engineering surfaces for substrate-mediated gene delivery using recombinant proteins.

Authors:  Jennifer C Rea; Romie F Gibly; Nicolynn E Davis; Annelise E Barron; Lonnie D Shea
Journal:  Biomacromolecules       Date:  2009-10-12       Impact factor: 6.988

8.  MPO (Myeloperoxidase) Caused Endothelial Dysfunction.

Authors:  Celine L Hartman; David A Ford
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-08       Impact factor: 8.311

9.  Neutralization of X4- and R5-tropic HIV-1 NL4-3 variants by HOCl-modified serum albumins.

Authors:  Svenja Polzer; Melanie van Yperen; Martin Kirst; Birco Schwalbe; Heiner Schaal; Michael Schreiber
Journal:  BMC Res Notes       Date:  2010-06-02

10.  Hypochlorite-modified high-density lipoprotein acts as a sink for myeloperoxidase in vitro.

Authors:  Gunther Marsche; Paul G Furtmüller; Christian Obinger; Wolfgang Sattler; Ernst Malle
Journal:  Cardiovasc Res       Date:  2008-02-23       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.